Coherus BioSciences
CHRS
#8813
Rank
ยฃ0.11 B
Marketcap
ยฃ0.96
Share price
7.04%
Change (1 day)
-27.72%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2025 (TTM): ยฃ65.1 Million

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is ยฃ62.71 Million. In 2024 the company made a revenue of ยฃ58.01 Million a decrease over the revenue in the year 2023 that were of ยฃ0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ65.1 M12.22%
2024 ยฃ58.01 M-71.27%
2023 ยฃ0.20 B15.75%
2022 ยฃ0.17 B-27.89%
2021 ยฃ0.24 B-30.7%
2020 ยฃ0.34 B28.56%
2019 ยฃ0.27 B
2018 N/A-100%
2017 ยฃ1.15 M-99.25%
2016 ยฃ0.15 B660.02%
2015 ยฃ20.27 M1.46%
2014 ยฃ19.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
ยฃ86.8 M 38.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
ยฃ0.27 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ26.99 B 42,943.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.53 B 747.08%๐Ÿ‡บ๐Ÿ‡ธ USA